Video
At AAN 2017, Peter Goadsby, M.B., B.S., Director of the NIHR- Wellcome Trust King’s Clinical Research, London, Professor of Neurology, University of California at San Francisco, discussed the recent FDA approval of the gammaCore non-invasive vagal nerve stimulator. Goadsby believed this would have a significant impact on patients with cluster headache. It’s an acute treatment; so it’s a way of treating the attacks that come.